Oxaliplatin Injection

Get a Price/Quote

Oxaliplatin Injection Specification

Salt Composition
Oxaliplatin

Dosage Form
Injection

Indication
Used in the treatment of advanced colorectal cancer

Feature
Sterile, ready-to-use injectable solution

Ingredients

Application

Ph Level
4.0 - 7.0

Physical Color/Texture
Clear, colorless to slightly yellow solution

Fermentation Smell
Odorless

Shelf Life
24 months

Oxaliplatin Injection Trade Information

Minimum Order Quantity
100 Piece

Payment Terms
Letter of Credit (L/C), Paypal, Western Union, Cash in Advance (CID), Cash Advance (CA)

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Export Market(s)
Australia, North America, Eastern Europe, Middle East, Western Europe, Africa, Central America, South America, Asia

Certifications
ISO, GMP, WHO

About Oxaliplatin Injection

Oxaliplatin Injection

Product Description

Fulfilling wide requirements of clients across global market place, we are highly reckoned for exporting an excellent stock of Oxaliplatin Injection. It belongs to a specific class of medicines called antineoplastic agent. This injection is used in combination with other medications for the treat of advanced colon or rectal cancer that begins in the large intestine. Oxaliplatin Injection is wisely formulated using supreme quality compounds in strict tandem with industry standards.

Features:

Recommended for use in combination with other medications for the prevention of colon cancer from spreading in people who have had surgery to remove the tumor
It works by killing cancer cells

Specifications:

Brand : Xylotin
Contain : Oxaplatin Inj
strength : 50mg /100mg
Packing :Vail

Advanced Chemotherapy Solution

Oxaliplatin Injection is a cytotoxic agent specifically used for treating advanced colorectal cancer. Its precise formulation ensures compatibility, sterility, and stability, all in compliance with international pharmacopeial standards. Packaged in clear glass vials, the solution maintains its integrity and effectiveness for up to 24 months when stored properly, offering reliable treatment options to healthcare providers.

Strict Handling and Storage Guidelines

Being a cytotoxic drug, Oxaliplatin Injection requires careful handling and administration by qualified healthcare professionals. It must be stored in cool conditions and away from direct sunlight to preserve its efficacy. The injection is supplied as a ready-to-use liquid, designed to minimize preparation time and risk of contamination, ensuring safety for medical staff and patients.

FAQs of Oxaliplatin Injection:

Q: How should Oxaliplatin Injection be administered?

A: Oxaliplatin Injection is administered intravenously by a qualified healthcare professional. It is for prescription use only and should never be given via other routes or self-administered.

Q: What precautions should be taken when handling Oxaliplatin Injection?

A: As a cytotoxic agent, the injection must be handled with care using protective equipment to prevent exposure. Preparation and administration should take place in designated areas, and only trained professionals should handle this product.

Q: Can Oxaliplatin Injection be mixed with other drugs or solutions?

A: No, Oxaliplatin Injection should not be mixed with alkaline drugs or infusion solutions. Compatibility with other medications must be confirmed before co-administration to avoid chemical interactions.

Q: Where should Oxaliplatin Injection be stored?

A: The injection should be stored in a cool environment, protected from direct sunlight, according to the manufacturers guidelines to maintain its stability and effectiveness. Do not freeze.

Q: When is Oxaliplatin Injection typically used in treatment?

A: It is used in the treatment of advanced colorectal cancer, often in combination with other chemotherapeutic agents, as prescribed by an oncologist.

Q: What are the benefits of using Oxaliplatin Injection in cancer therapy?

A: It is a widely studied antineoplastic agent with proven efficacy in prolonging survival and improving treatment outcomes for patients with advanced colorectal cancer, particularly when included in combination regimens.

Tell us about your requirement